A Sick Way to Promote Drugs
Submitted by Diane Farsetta on
"I've never been on the opposite side of the No
Main Source:
Topics:
Pharmaceuticals
Lavishing Doctors with Drug Money
Submitted by Bob Burton on
Medicines Australia (MA), the peak drug industry lobby group, has unveiled details of how much its 42 member companies (and one non-member) spent in the last half of 2007 on each one of over 14,000 events that were designed to promote their drugs to doctors.
No
Main Source:
Topics:
Pricing Doctors
Submitted by Bob Burton on
A proposal before the Massachusetts state Senate to ban drug company gifts to doctors is generating controversy. "To imply that doctors who have invested years and tens of thousands of dollars in their profession can be bought with a dinner or a package of Post-its is beneath contempt," wrote the husband of one doctor. But Dr. Daniel J.
No
Main Source:
Telling It Like It Is
Submitted by Bob Burton on
The director of external relations for Procter & Gamble, Mark Chakravarty, recently told a UK healthcare PR conference that the drug industry is less than popular with the public. "There is a high suspicion of the pharma industry. Greed, dishonesty and fraud are some of its associations. The clinical trial press this week and an increased number of drug scandals add to this image," he said.
No
Main Source:
Topics:
Big Pharma's Health Care Reform Playbook
Submitted by Sheldon Rampton on
"Congress' ability to curb the explosive rise in drug costs is a bellwether of the political prospects for health care reform," writes Merrill Goozner.
No
Main Source:
Medical Disclosure Riles Professor
Submitted by Bob Burton on
No
Main Source:
Pfizer Pulls Deceptive Lipitor Ads
Submitted by Anne Landman on
Drug maker No
Main Source:
The Invisible Hands Guiding Doctors' Continuing Education
Submitted by Bob Burton on
Ray Moynihan reveals that while educational events have been advertised to Australian medical practitioners as being independent, behind the scenes sponsoring drug companies were being offered the chance to nominate speakers and topics relating to their drugs.
No
Beyond Advertising: The Pharmaceutical Industry's Hidden Marketing Tactics
In early January, the U.S. House Committee on Energy and Commerce began investigating celebrity endorsements in television ads for brand-name drugs. The investigation was sparked by Pfizer's commercials for its best-selling cholesterol drug Lipitor. These direct-to-consumer (DTC) ads feature Dr. Robert Jarvik, a pioneer in the development of the artificial heart. Viewers are not told that Jarvik is not a cardiologist, nor is he licensed to practice medicine. His presentation as a trusted expert, Pfizer presumably hopes, is enough to persuade viewers to ask their doctors for Lipitor by name. And that would help erode the increasing competition from generic alternatives.
Merck Minimizes Accusations It Swindled the U.S. Government
Submitted by Anne Landman on
The pharmaceutical company Merck agreed to a $650 million settlement to escape charges that it routinely overbilled the U.S. government for medicines.
No
Main Source:
Pages
